Technology Press Releases
SEE OTHER BRANDS

Get your fresh news on technology in the world

Technology Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.

Press releases published on April 22, 2025

EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting

EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting

Activities to include expert-led demonstrations, semi-live Focal One procedures and hands-on simulations Final results of randomized clinical trial (FARP Study) comparing ultrasound-based focal ablation versus radical prostatectomy as a first-line …

Solaris completes Warintza drilling campaign and advances key de-risking milestones ahead of major near-term value catalysts

Solaris completes Warintza drilling campaign and advances key de-risking milestones ahead of major near-term value catalysts

HIGHLIGHTS: Solaris completes significant drilling campaign at its flagship Warintza project 82,000 metres of infill drilling Updated Mineral Resource Estimate targeted for Q3 2025 Step-out field exploration activities are ongoing Technical approval of the …

FundThrough Acquires Ampla, Strengthening its Digital-First Invoice Funding Solution

FundThrough Acquires Ampla, Strengthening its Digital-First Invoice Funding Solution

HOUSTON and TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- FundThrough, the leading fintech invoice factoring platform for small and medium-sized businesses (SMBs), today announced its acquisition of Ampla, the leading provider of financial technology …

Axonius Launches Exposures – A Breakthrough Product to Unify Security, Asset, and Business Context in a Single Platform

Axonius Launches Exposures – A Breakthrough Product to Unify Security, Asset, and Business Context in a Single Platform

NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today announced the launch of Axonius Exposures, a groundbreaking solution that transforms Risk …

PolyPid to Participate in The Citizens Life Sciences Conference

PolyPid to Participate in The Citizens Life Sciences Conference

PETACH TIKVA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Company’s management will participate in a …

Best Retargeting Ads Platform (2025): Meta Pixel Recognized As Top Ad Retargeting Solution by Software Experts

Best Retargeting Ads Platform (2025): Meta Pixel Recognized As Top Ad Retargeting Solution by Software Experts

NEW YORK CITY, April 22, 2025 (GLOBE NEWSWIRE) -- Software Experts has recognized Meta Pixel as a top solution for ad retargeting, emphasizing its role in helping businesses optimize ad performance and improve conversion rates.  Top Ad Retargeting Platform …

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

ST. LOUIS, April 22, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2025 first quarter on …

Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader

Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader

Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25 Completed SAD/MAD dosing in KT-621 Phase 1 healthy volunteer trial with data to be reported in June 2025 Two parallel Phase 2b trials in AD and asthma …

HydroGraph Announces $2.2M in Warrant Exercise and AGM Results

HydroGraph Announces $2.2M in Warrant Exercise and AGM Results

VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: ‎HG) (OTCQB: HGCPF) (the “Company” or “HydroGraph”) a leading commercial manufacturer of pristine graphene, is pleased to announce that it has raised over $2. …

InStride’s Hybrid Clinical Cohorts Fill High-Need Roles in Healthcare

InStride’s Hybrid Clinical Cohorts Fill High-Need Roles in Healthcare

LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- InStride, a human capital management company providing strategic education benefits, today announced a hybrid education model that empowers healthcare organizations to fill critical roles by developing talent …

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and increased cardiovascular risk BDD also encompasses pacemaker-indicated patients with uncontrolled hypertension …

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Rapport Therapeutics to Participate in Upcoming Investor Conferences

BOSTON and SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …

Medicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference

Medicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference

TORONTO and HOUSTON, April 22, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune …

Voice2Me.ai Launches Ultra-Secured AI Voice Agents Intelligence Platform for ServiceNow

Voice2Me.ai Launches Ultra-Secured AI Voice Agents Intelligence Platform for ServiceNow

Fairfax, Virginia, April 22, 2025 (GLOBE NEWSWIRE) -- Voice2Me.ai officially announces the launch of the industry’s first ultra-secured AI voice agents intelligence platform, now available for ServiceNow clients. The platform introduces a ServiceNow-native …

One of U.S.’s Largest Drone Manufacturers of Small-Sized Drones Places its 6th Production Scale Order for Mobilicom’s Cybersecure Drone Solutions

One of U.S.’s Largest Drone Manufacturers of Small-Sized Drones Places its 6th Production Scale Order for Mobilicom’s Cybersecure Drone Solutions

Demonstrates continuous growth through ongoing re-orders from Tier-1 manufacturers Customer’s drones are gaining strong traction with U.S. Department of Defense (DoD) and other defense purchasers Palo Alto, California, April 22, 2025 (GLOBE NEWSWIRE) --   …

DN Miner Unveils Next-Generation Mining Infrastructure with Enhanced Security and Performance

DN Miner Unveils Next-Generation Mining Infrastructure with Enhanced Security and Performance

London, UK, April 22, 2025 (GLOBE NEWSWIRE) -- DN Miner, a leading cryptocurrency mining service provider certified by the UK Financial Conduct Authority (FCA), today announced major upgrades to its cloud mining infrastructure, marking a significant …

Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody

Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody

- Initiation of Upcoming Phase 1a/1b Clinical Trial Expected in the Second Quarter of 2025 - WAYNE, Pa, April 22, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel …

Northrop Grumman Releases First Quarter 2025 Financial Results

Northrop Grumman Releases First Quarter 2025 Financial Results

FALLS CHURCH, Va., April 22, 2025 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE: NOC) has released its first quarter 2025 financial results. A copy of the earnings release has been furnished in the company’s Form 8-K filing and is also available …

Verizon delivered strong financial growth with industry-leading wireless service revenue in 1Q 2025

Verizon delivered strong financial growth with industry-leading wireless service revenue in 1Q 2025

Customer segmentation strategy is a key driver of successful financial performance Verizon remains confident in full-year 2025 guidance Key 1Q 2025 Highlights Industry-leading total wireless service revenue1 of $20.8 billion Best wireless retail core …

Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)

Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)

TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University Health Network (UHN) Research Ethics Board has granted approval for Toronto General …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service